Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: - | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics in vitro / ex vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Title:
- Unnamed
- Year:
- 2 021
Materials and methods
- Objective of study:
- bioaccessibility (or bioavailability)
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- An internationally agreed guideline does not exist yet for this test (e.g. OECD). However, a bioelution test method to assess the relative in vitro bioaccessibility (IVBA) of metals and metalloids in inorganic metal compounds and metal (metalloid)-containing materials was submitted to EURL ECVAM. Further, similar tests have been conducted with several metal compounds incl. steels in previous risk assessments (completed under Regulation (EEC) No 793/93) or in recent preparations for REACH regulation (EC) No 1907/2006.
Therefore, the test was performed on the basis of the guidance for OECD-Series on testing and assessment Number 29 (OECD Guideline 29: 2001; ENV/JM/MONO(2001)9), the bioelution test method reported in the ESAC opinion and bioaccessibility methods reported in published studies.
This report describes the measured bioaccessibility of ALFERROCK in body fluid simulants GST (Artificial gastric fluid), PBS (Phosphate buffered saline), GMB (Gamble´s solution), ALF (Artificial lysosomal fluid) and ASW (Artificial sweat solution) as a surrogate for potential bioavailability of different species contained in ALFERROCK.
The test adopted experimental conditions of the OECD 29 guidance: 24 h agitation at 100 rpm in the dark on an incubated laboratory shaker (Shaking incubation cabinet “Minitron”, INFORS AG, Bottmingen, Switzerland). The temperature in the thermostatically controlled incubation cabinet was adjusted to 37.5°C to obtain a medium temperature of 37 ± 1°C to simulate the human body temperature. Furthermore, the test with GMB was performed in a 5% CO2 atmosphere.
Three replicates and two method blanks per artificial medium were tested. An additional fourth replicate was included for pH measurements during testing. Solutions of three test vessels and two method blanks were sampled after 2 h and 24 h whereas GMB and ALF were also sampled after 168 h. The element concentrations of Al, Ca, Cr, Fe, P, S, Si, Ti, V and Zr were measured after filtration (0.2 µm) and after additional centrifugal filtration (i.e. 0.2 µm and 3 kDa) by ICP-OES. The pH of the three test replicates were measured before test start and at test end. The solution pH of method blanks and the additional fourth replicate was measured at test start, after 2 h, 24 h and 168 h (only ALF and GMB). - GLP compliance:
- yes (incl. QA statement)
Test material
- Reference substance name:
- Neutralisation and reduction products of bauxite residue from refinement process
- Molecular formula:
- The substance is a UVCB for which it is not possible to provide a molecular formula and a molecular weight.
- IUPAC Name:
- Neutralisation and reduction products of bauxite residue from refinement process
- Test material form:
- solid
Constituent 1
- Specific details on test material used for the study:
- Lot number: 00-00 05 03
Appearance: reddish brown powder
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
- For the test, 1 g of the test item was transferred into 500 mL Erlenmeyer flasks. A volume of 500 mL of test medium was added to the flask to obtain a loading of 2 g/L. - Radiolabelling:
- no
Test animals
- Species:
- other: not applicable
- Details on test animals or test system and environmental conditions:
- not applicable
Administration / exposure
- Route of administration:
- application in vitro
- Vehicle:
- other: artificial body fluids
- Details on exposure:
- IN VITRO APPLICATION
- Concentration of test material: 2 g/l. 1 g of the test item was transferred into 500 mL Erlenmeyer flasks. A volume of 500 mL of respective test medium was added to the flask to obtain a loading of 2 g/L
- Method of preparation of stock solution(s) of test material and reference chemical:
For the analysis of Si a single element standard was used and diluted with the respective medium to obtain the matrix matched calibration standard solutions.
For the analysis of Al, Ca, Cr, Fe, P, S, Ti, V and Zr the respective single element standards were mixed to prepare a stock solution containing 100 mg/L of Al, Ca, Fe, P, S and Ti and 10 mg/L Cr, V and Zr in 10 % HNO3. This stock solution was further diluted with the respective medium to obtain the matrix matched calibration standard solutions.
For more information on concentrations of standard solutions, please refer to section "Any other information on materials and methods incl. tables".
- Cell culture medium characteristics (temperature, pH): The temperature of the media was hold in the range 37 °C ± 1 °C during the test period. For more information on pH of the test media, please refer to "Any other information on materials and methods, incl. tables".
- Incubation temperature: The temperature in the thermostatically controlled incubation cabinet was adjusted to 37.5°C to obtain a medium temperature of 37 ± 1°C to simulate the human body temperature. Furthermore, the test with GMB was performed in a 5% CO2 atmosphere.
- Number of replicates (if more than one is used per run): Three replicates and two method blanks per artificial medium were tested. An additional fourth replicate was included for pH measurements during testing.
- Number of independent runs: At least three internal measurements for each sample were performed and the mean was calculated and printed by the instrument software.
- Time points: GST, PBS and ASW media were sampled after 2 h and 24 h, whereas GMB and ALF media were sampled additionally after 168 h. - Duration and frequency of treatment / exposure:
- Solutions of test vessels and method blanks were sampled after 2 h and 24 h, whereas GMB and ALF were also sampled after 168 h.
Doses / concentrations
- Dose / conc.:
- 2 other: g/L
- Remarks:
- 1 g of the test item was transferred with 500 mL of test medium was added to a 500 mL flask to obtain a loading of 2 g/L.
- No. of animals per sex per dose / concentration:
- not applicable
- Control animals:
- not relevant
- Positive control reference chemical:
- not applicable
- Details on study design:
- For the test, 1 g of the test item was transferred into 500 mL Erlenmeyer flasks. A volume of 500 mL of test medium was added to the flask to obtain a loading of 2 g/L. The volume of the media was adjusted as necessary for a precise loading.
Three replicates and two method blanks per artificial medium were tested. An additional fourth replicate was included for pH measurements during testing. The vessels containing the test item were agitated with 100 rpm in the dark on an incubated laboratory shaker (Shaking incubation cabinet “Minitron”, INFORS AG, Bottmingen, Switzerland). Agitation was sufficient to maintain the flow of aqueous medium over the test substance while maintaining the integrity of the surface of the test substance and of any solid reaction product coatings formed during the test. The temperature of the media in the thermostatically controlled incubation cabinet was adjusted to 37.5°C to obtain a medium temperature of 37 ± 1°C to simulate the human body temperature. Furthermore, the test with GMB was performed in a 5% CO2 atmosphere in order to keep the pH stable during the test. Solutions of three test vessels and two method blanks were sampled after 2 h and 24 h whereas GMB and ALF were also sampled after 168 h. The element concentrations were measured after filtration (0.2 µm) and after additional centrifugal filtration (i.e. 0.2 µm and 3 kDa) by ICP-OES. The pH of the three test replicates were measured before test start and at test end. The solution pH of method blanks and the additional fourth replicate was measured at test start, after 2 h, 24 h and 168 h (only ALF and GMB).
Because silicon was analysed in the bioaccessibility tests, the apparatus consisted of open polypropylene flasks in a thermostatically controlled shaking incubator (Minitron-incubation-shaking-device, INFORS AG, Bottmingen, Switzerland) with the possibility for the addition of CO2 to keep the pH stable within the experimental phase. The aluminium foil used standardly was avoided because Al is one of the metals to be analysed. Instead, the exchange with the atmosphere was realized through parafilm with a hole.
Solution pH during the samplings was measured at sampling using a Multi 9430 device equipped with Sentix 940-P electrodes (WTW, Weilheim, Germany) directly in the test vessels. Measurements were taken after readings had stabilized. The pH electrode was calibrated or checked on each sampling day.
Four replicate vessels containing the test material and two control blanks per artificial media were tested. Whereas three replicate vessels containing the test material are used for sampling, one replicate vessel containing the test material and the two control vessels are used for pH measurements at each sampling (blank control vessels were sampled too). However, after the last sampling (24 h for GST, PBS and ASW, 168 h for ALF and GMB), the pH of all test solutions (four replicates plus two control vessels) was measured. A pH meter showing acceptable results within ± 0.01 pH units was used. Before inserting into each vessel, electrode and sensor were rinsed thoroughly with purified water to avoid cross-contamination. Furthermore, a data logger measured the temperature during the test. Solutions were examined for soapy bubbles or floating particles on the surface. - Details on dosing and sampling:
- GST, PBS and ASW media were sampled after 2 h and 24 h, whereas GMB and ALF media were sampled additionally after 168 h. Subsequent to the sampling after 24 h, the media GMB and ALF were replenished with new medium in equal volume to that already drawn. Solutions for analytical measurements were sampled with a pipette in duplicate per vessel and sampling point. A total of 4 × 30 mL (ASW medium only 2 × 30 mL sampling because no silicon analysis is necessary) were sampled and filtered through a 0.2 µm polyethersulfone (PES) membrane syringe filter. A subsample of 15 mL of each sample was subsequently filtered through a centrifugal filter (i.e., 3 kDa filter, Vivaspin, Sartorius, Germany). The subsamples of the 0.2 µm filtered and the additionally 3 kDa centrifugally filtered samples were acidified with 69% HNO3 (e.g., 150 µL for 15 mL sample) and stored at approx. 4 °C until analysis.
The two subsamples intended for silicon analysis were alkalized with 10% NaOH (e.g., 150 µL for 15 mL sample) for GST medium and with 50% NaOH (e.g., 150 µL for 15 mL sample) for ALF medium. For PBS medium, neither acidification nor alkalinization was performed. The samples of the test with GMB were acidified with 69% HNO3 (e.g., 150 µL for 15 mL sample). Since it cannot be guaranteed that the dissolved/dispersed Si concentration remains stable in filtrates, the silicon concentration was quantified within 1 day after sampling, if feasible. - Statistics:
- N/A
Results and discussion
- Preliminary studies:
- not applicable
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- not applicable
- Details on distribution in tissues:
- not applicable
Metabolite characterisation studies
- Metabolites identified:
- no
- Details on metabolites:
- not applicable
Enzymatic activity
- Enzymatic activity measured:
- N/A
Bioaccessibility (or Bioavailability)
- Bioaccessibility (or Bioavailability) testing results:
- The highest concentrations of all elemental species investigated was found for aluminum in artificial gastric fluid and artificial lysosomal fluid, simulating the harsh digestion milieu in the stomach and intracellular conditions in lung cells occurring with phagocytosis, respectively.
In addition, elevated levels of silicon were found after incubation of the test material in these fluids.
Relevant dissolution was also found for Calcium, Iron, Phosphorous, Sulfur, and Titanium.
For more details and quantitative results, please refer to section "Any other information on results incl. tables".
Any other information on results incl. tables
Table 1: Summary of bioaccessibility of various tested compounds
GST [µg/g Alferrock] | PBS [µg/g Alferrock] | ASW [µg/g Alferrock] | ALF [µg/g Alferrock] | GMB [µg/g Alferrock] | ||||||||
2h | 24h | 2h | 24h | 2h | 24h | 2h | 24h | 168h | 2h | 24h | 168h | |
Aluminum | 17236.5 | 28094.7 | 11.6 | 71.5 | 33.2 | 150.3 | 20118.0 | 27855.0 | 24426.0 | 15.4 | 334.3 | 754.5 |
Calcium | 6808.2 | 10261.7 | 391.0 | 872.5 | 1052.3 | 3056.7 | - | - | - | - | - | - |
Chromium | 6.8 | 26.3 | 0.9 | 0.7 | 0.2 | 0.2 | 7.5 | 22.1 | 47.1 | 0.3 | 0.4 | 0.4 |
Iron | 214.9 | 1242.5 | 0.1 | 0.1 | neg value due to higher blank | 342.0 | 1522.0 | 3744.0 | 0.3 | 1.5 | 0.3 | |
Phosphorous | 375.0 | 215.6 | - | - | 21.5 | 20.6 | - | - | - | - | - | - |
Sulfur | 563.7 | 891.5 | 49.2 | 194.0 | 66.5 | 117.0 | - | - | - | - | - | - |
Silicon | 12657 .9 | 11559.7 | 210.2 | 2797.6 | - | - | 18719.0 | 23735.0 | 23137.9 | 102.5 | 907.8 | 2487.6 |
Titanium | 85.9 | 495.3 | <LOD | <LOD | 0.2 | 0.1 | 86.5 | 566.5 | 1979.0 | 0.1 | 0.1 | 0.1 |
Vanadium | 10.2 | 21.9 | - | - | 0.9 | 3.7 | - | - | - | 2.5 | 12.7 | 19.6 |
Zirconium | 0.9 | 2.0 | <LOD | <LOD | 0.1 | 0.1 | 12.2 | 42.1 | 110.5 | 0.2 | 0.2 | 0.2 |
GST: Artificial gastric fluid
GMB: Gamble´s solution
ALF: Artificial lysosomal fluid
ASW: Artificial sweat
PBS: Phosphate buffered saline
Applicant's summary and conclusion
- Conclusions:
- The objective of this study was to investigate the dissolution rate of the test item "Neutralisation and reduction products of bauxite residue from refinement process" in different artificial physiological media GST, PBS, GMB, ALF and ASW, representing the oral, dermal and inhalation routes of exposure as a measure for bioaccessibility.
The highest concentrations of all elemental species investigated was found for aluminum in GST (artificial gastric fluid) and ALF (artificial lysosomal fluid). In addition, elevated levels of silicon were found after incubation of the test material in these fluids.
Relevant dissolution was also found for Calcium, Iron, Phosphorous, Sulfur, and Titanium. - Executive summary:
In this bioaccessibility study which was performed on the basis of OECD Series on Testing and Assessment No. 29 (2001; ENV/JM/ MONO(2001)9), the test item "Neutralisation and reduction products of bauxite residue from refinement process" was incubated in different artificial physiological media at a concentration of 2 g/l in a total volume of 500 ml in order to determine the dissolution rate of the elemental species aluminium, iron, titanium, calcium, zirconium, sulfur, chromium, phosphorus, vanadium and silicon contained in the material.
The media were selected to represent the conditions after exposure via the oral, dermal and inhalation route of exposure (ALF, Artificial lysosomal fluid (pH = 4.5)/ ASW, Artificial sweat solution (pH = 6.5)/ GMB, Gamble´s solution (pH = 7.4)/ GST, Artificial gastric fluid (pH = 1.5) and PBS, Phosphate buffered saline (pH = 7.4)).
For the experimental setup, the test item was incubated in the different artificial physiological media in the dark at 100 rpm and at 37 °C ± 1 °C. Samples of GST, ASW and PBS medium were taken after 2 h and 24 h whereas GMB and ALF samples were taken after 2 h, 24 h and 168 h (7 days). Respective element concentrations of filtered solutions were determined by ICP-OES.
The highest concentrations of all elemental species investigated was found for aluminum in artificial gastric fluid and artificial lysosomal fluid, simulating the harsh digestion milieu in the stomach and intracellular conditions in lung cells occurring with phagocytosis, respectively. In addition, elevated levels of silicon were found after incubation of the test material in these fluids. Relevant dissolution was also found for Calcium, Iron, Phosphorous, Sulfur, and Titanium.
For more details and quantitative results, please refer to section "Any other information on results incl. tables".
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
